Ola Landgren, MD, PhD

home / tumor-board / ola-landgren-md-phd

Multiple Myeloma Cancer Chair

Chief, Myeloma Program

Leader, Experimental Therapeutics Program

Sylvester Comprehensive Cancer Center

Professor of Medicine

University of Miami

Miami, FL


Hematologic oncologist, Ola Landgren, MD, PhD, was recently appointed the inaugural leader of a new research program, Experimental Therapeutics, at Sylvester Comprehensive Cancer Center at the University of Miami Health System and the Miller School of Medicine. Landgren completed his medical degree and doctorate at Karolinska Institute in Stockholm, Sweden. He is board certified in hematology and internal medicine. As part of his ongoing research program, Landgren is studying molecular mechanisms underlying the trajectory from precursor to full-blown multiple myeloma with the goal to develop treatment strategies aiming to delay, prevent, and ultimately define a cure for multiple myeloma.